Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions
NCT01884896
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Fasting
Interventions
DRUG:
Metoprolol Succinate ER Tablet 200 mg
DRUG:
'TOPROL-XL®' ER Tablets 200 mg
Sponsor
IPCA Laboratories Ltd.